Patents
Patents for C07C 317 - Sulfones; Sulfoxides (15,874)
11/2002
11/07/2002WO2002088061A1 Novel atisane compound and use thereof
11/07/2002US20020165406 Methods of synthesizing acylanilides including bicalutamide and derivatives thereof
11/07/2002US20020165394 Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
11/07/2002US20020165236 Such as 3-(3-(4-(4-sulfamoyl-benzylsulfamoyl-phenyl)-ureido)-benzamidine for treatment of malaria
11/07/2002US20020165232 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002US20020165231 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002US20020165096 Applying to weeds
11/07/2002US20020165095 Herbicidally active benzoylcyclohexanediones
11/06/2002EP1254136A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
11/06/2002EP1012137B1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
11/05/2002US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity
11/05/2002US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
11/05/2002US6476027 N-hydroxy 4-sulfonyl butanamide compounds
11/05/2002US6476026 Compounds and compositions as protease inhibitors
10/2002
10/31/2002WO2002085843A2 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
10/31/2002WO2002076918A8 NF-λB INHIBITOR CONTAINING SUBSTITUTED BENZOIC ACID DERIVATIVE AS ACTIVE INGREDIENT
10/31/2002WO2001070675A3 Inhibitors of histone deacetylase
10/31/2002WO2001058855A9 Use of androgen receptor suppressors
10/31/2002US20020161234 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde
10/31/2002US20020161225 Phenylurethane compounds and methods for producing same, asymmetric urea compounds and methods for producing same, barbituric acid derivative, and diazo thermal recording material containing the derivative
10/31/2002US20020161053 Inflammatory cytokine production inhibitors, matrix metalloprotease production inhibitors, inflammatory cell adhesion molecules incidence inhibitors, antiinflammatory agents
10/31/2002US20020161041 Resorcinol derivatives
10/31/2002US20020160982 Modafinil compound and cyclodextrin mixtures
10/31/2002CA2443946A1 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
10/30/2002EP1253128A1 Perfluoroisopropylbenzene derivatives
10/30/2002EP1252152A1 Urea compounds as inhibitors for vla-4
10/30/2002EP1252133A2 Pharmaceutical compounds
10/30/2002EP1162962A4 Alkynyl aryl sulfones
10/30/2002EP1105359B1 Solid phase synthesis of compounds by carbon-carbon bond forming mitsunobu reactions
10/30/2002CN1377340A Phenolic compounds and recording materials containing the same
10/29/2002US6472415 Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
10/29/2002US6472414 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
10/29/2002US6472412 Compounds as PDE IV and TNF inhibitors
10/29/2002US6472407 α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/24/2002WO2002083630A1 Oxalic acid derivatives
10/24/2002WO2002083608A2 Methods of preparing sulfinamide and sulfoxides
10/24/2002US20020156275 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position
10/24/2002US20020156113 Farnesyl transferase inhibitors; anticancer agents
10/24/2002CA2445538A1 Oxalic acid derivatives
10/23/2002EP1250629A1 Packaged color photographic film comprising a blocked phenylenediamine developing agent and a method for processing the film
10/23/2002CN1375357A Amorphous alloy catalyst for hydrogenating cyclobufene sultone and its prepn. and application
10/23/2002CN1093110C Polyene alcohol derivative and process for producing the same
10/22/2002US6468999 Treating anxiety, depression and other central nervous system disorders in humans and animals
10/17/2002WO2002081435A1 Sulphones which modulate the action of gamma secretase
10/17/2002WO2002081434A1 Derivatives of benzoylcyclohexanedione and their use as herbicides
10/17/2002WO2002081433A1 Sulphones which modulate the action of gamma secretase
10/17/2002WO2002081432A2 Sulfoxides or sulfones grafted onto polymers
10/17/2002US20020151586 Antidiabetic agents
10/17/2002DE10117823A1 New N-phenyl-oxalamide derivatives, are factor Xa and factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, inflammation, angina pectoris or tumor diseases
10/17/2002DE10117503A1 Derivate von Benzoylcyclohexandionen und ihre Verwendung als Herbizide Derivatives of benzoylcyclohexanediones and their use as herbicides
10/16/2002EP1248777A2 Tricyclic compounds with antiviral activity
10/16/2002EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/16/2002EP0538477B1 Novel cyclic aminophenylacetic acid derivative, production thereof, and immune response modulator containing the same as active ingredient
10/16/2002CN1374946A Substituted aromatic-ring compounds, process for producing the same, and us
10/16/2002CN1374940A O-Anisamide derivatives
10/15/2002US6465663 Ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-naphthalen-8(7h)-one-2 -yl)ethenyl)benzoate and ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-8-(phenylthio)-naphthalenyl)ethenyl) benzoate
10/15/2002US6465457 Carbonate, carbamate, thiocarbonate dithiocarbonate and thiocarbomate derivatives useful as fungicides
10/10/2002WO2002079131A1 Optically active compound and photosensitive resin composition
10/10/2002WO2002079122A2 Methods of synthesizing phenol-containing compounds
10/10/2002WO2002078693A2 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
10/10/2002WO2002062763A3 Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas
10/10/2002WO2001072685A9 Polyamine analogues as cytotoxic agents
10/10/2002US20020147342 Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors
10/10/2002US20020147337 Antilipemic agents; chemical interemdiates
10/10/2002US20020147336 Glucocorticoid receptor modulators
10/10/2002US20020147234 Nitrate esters and methods of making same
10/10/2002CA2442480A1 Methods of synthesizing phenol-containing compounds
10/09/2002EP1246795A2 Antibacterial agents
10/09/2002EP1246625A2 Methods and compositions for mitigating pain using nitrate esters
10/09/2002EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/09/2002EP0679082B1 C10 taxane derivatives and pharmaceutical compositions
10/09/2002CN1373751A 'Alpha'-amino-'beta'-sulfonyl hydroxamic acid compounds
10/09/2002CN1373750A 2'-substd. 1,1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds
10/09/2002CN1373112A Method for producing allyl halide
10/08/2002US6462238 Process for the reduction of cyano-substituted sulfones to aminoalkylene-substituted sulfones
10/08/2002US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases
10/08/2002US6462073 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
10/03/2002WO2002076939A2 Cysteine protease inhibitors
10/03/2002WO2002076934A2 Purification of 2-nitro-4-methylsulphonylbenzoic acid
10/03/2002WO2002076930A2 Substituted diarylureas as stimulators for fas-mediated apoptosis
10/03/2002WO2002076929A1 Aryl and biaryl compounds having mch modulatory activity
10/03/2002WO2002076918A1 NF-λB INHIBITOR CONTAINING SUBSTITUTED BENZOIC ACID DERIVATIVE AS ACTIVE INGREDIENT
10/03/2002WO2002076395A2 Agents and methods for treatment of cancer
10/03/2002WO2002030880A3 N-substituted amino acid derivatives (factor xa inhibitors)
10/03/2002US20020143205 Reacting pivaloyl chloride with hydroxyketosulfide compound and trialkylamine in the presence of a catalyst in a substantially non-reactive solvent to form ketoester sulfide compound; oxidizing to form ketoester sulfone compound
10/03/2002US20020143186 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity
10/03/2002US20020143177 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits
10/03/2002US20020143040 Having antipyretic action, analgesic action, anti-inflammatory action;side effect reduction
10/03/2002US20020143003 As serotonin, norepinephrine and dopamine reuptake inhibitors, for therapy of central nervous system and other disorders
10/03/2002CA2441394A1 Agents and methods for treatment of cancer
10/03/2002CA2434020A1 Substituted diarylureas as stimulators for fas-mediated apoptosis
10/03/2002CA2410816A1 Nf-.kappa.b inhibitor containing substituted benzoic acid derivative as active ingredient
10/02/2002EP1245555A1 Halogenated aromatic compound, polymer thereof, and proton-conductive membrane comprising same
10/02/2002DE10112040A1 Verbessertes Verfahren zur Herstellung von Sulfonylcarboxamidderivaten An improved process for the preparation of Sulfonylcarboxamidderivaten
10/02/2002CN1091594C Use of anti-viral compound in preparing medicine for curing virus infection
10/01/2002US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
10/01/2002US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes
10/01/2002US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
10/01/2002US6458775 NAALADase inhibitors useful as pharmaceutical compounds and compositions
09/2002
09/26/2002WO2002074762A1 Process for producing sulfone derivative
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 159